-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Lifecore Biomedical, Inc. \De\ quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q3 2010 to Q3 2024.
- Lifecore Biomedical, Inc. \De\ Net Cash Provided by (Used in) Investing Activities for the quarter ending August 25, 2024 was -$3.39M, a 32.9% increase year-over-year.
- Lifecore Biomedical, Inc. \De\ annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$17.9M, a 273% decline from 2022.
- Lifecore Biomedical, Inc. \De\ annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$4.81M, a 106% decline from 2021.
- Lifecore Biomedical, Inc. \De\ annual Net Cash Provided by (Used in) Investing Activities for 2021 was $80M.
Net Cash Provided by (Used in) Investing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)